PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Orth, M.F.* ; Surdez, D.* ; Faehling, T.* ; Ehlers, A.C.* ; Marchetto, A.* ; Grossetete, S.* ; Volckmann, R.* ; Zwijnenburg, D.A.* ; Gerke, J.S.* ; Zaidi, S.* ; Alonso, J.* ; Sastre, A.* ; Baulande, S.* ; Sill, M.* ; Cidre-Aranaz, F.* ; Ohmura, S.* ; Kirchner, T.* ; Hauck, S.M. ; Reischl, E. ; Gymrek, M.* ; Pfister, S.M.* ; Strauch, K. ; Koster, J.* ; Delattre, O.* ; Grunewald, T.G.P.*

Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation.

Cell Rep. 41:111761 (2022)
Postprint DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Ewing sarcoma (EwS) is characterized by EWSR1-ETS fusion transcription factors converting polymorphic GGAA microsatellites (mSats) into potent neo-enhancers. Although the paucity of additional mutations makes EwS a genuine model to study principles of cooperation between dominant fusion oncogenes and neo-enhancers, this is impeded by the limited number of well-characterized models. Here we present the Ewing Sarcoma Cell Line Atlas (ESCLA), comprising whole-genome, DNA methylation, transcriptome, proteome, and chromatin immunoprecipitation sequencing (ChIP-seq) data of 18 cell lines with inducible EWSR1-ETS knockdown. The ESCLA shows hundreds of EWSR1-ETS-targets, the nature of EWSR1-ETS-preferred GGAA mSats, and putative indirect modes of EWSR1-ETS-mediated gene regulation, converging in the duality of a specific but plastic EwS signature. We identify heterogeneously regulated EWSR1-ETS-targets as potential prognostic EwS biomarkers. Our freely available ESCLA (http://r2platform.com/escla/) is a rich resource for EwS research and highlights the power of comprehensive datasets to unravel principles of heterogeneous gene regulation by chimeric transcription factors.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Altmetric
9.995
0.000
4
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Chip-seq ; Cp: Cancer ; Enhancer ; Ewing Sarcoma ; Ewsr1-erg ; Ewsr1-ets ; Ewsr1-fli1 ; Microsatellites ; Multi-omics ; Pediatric Sarcoma ; Tumor Heterogeneity; Transcription Factor; Ewsr1-fli1 Activity; Genomic Landscape; Tumor; Expression; Target; Ews-fli1; Generation; Chromatin; Elements
Sprache englisch
Veröffentlichungsjahr 2022
HGF-Berichtsjahr 2022
ISSN (print) / ISBN 2211-1247
e-ISSN 2211-1247
Zeitschrift Cell Reports
Quellenangaben Band: 41, Heft: 10, Seiten: , Artikelnummer: 111761 Supplement: ,
Verlag Cell Press
Verlagsort 50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Begutachtungsstatus Peer reviewed
Institut(e) CF Metabolomics & Proteomics (CF-MPC)
Institute of Genetic Epidemiology (IGE)
POF Topic(s) 30203 - Molecular Targets and Therapies
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er) Enabling and Novel Technologies
Genetics and Epidemiology
PSP-Element(e) G-505700-001
G-504100-001
A-630700-001
Förderungen LMU Munich's Institutional Strategy LMUexcellent within the framework of the German Excellence Initiative
Mehr LEBEN fur Krebskranke Kinder - Bettina-Brau-Stiftung
Wilhelm Sander Foundation
Friedrich-Baur Foundation
Matthias Lackas Foundation
Dr. Leopold und Carmen Ellinger Foundation
Deutsche Forschungsgemeinschaft
SMARCB1 Association
German Cancer Aid
Boehringer Ingelheim Foundation
Barbara and Wilfried Mohr Foundation
Helmholtz Zentrum Munchen - German Research Center for Environmental Health
Munich Center of Health Sciences (MC-Health) as part of LMUinnovativ
EU
Agence Nationale de la Recherche ("Investissements d'Avenir" program)
Canceropole Ile-de-France
SiRIC-Curie program - SiRIC
Heinrich F.C. Behr Foundation
Federal Ministry of Education and Research
DOI 10.1016/j.celrep.2022.111761
WOS ID 000907579500001
WOS ID WOS:000907579500001
Scopus ID 85143554828
PubMed ID 36476851
Erfassungsdatum 2022-12-15
[➜Korrektur melden]